miRNA-126-3p carried by human umbilical cord mesenchymal stem cell enhances endothelial function through exosome-mediated mechanisms in vitro and attenuates vein graft neointimal formation in vivo.
Qingxi QuLimei WangWeidong BingYanwen BiChunmei ZhangXuanxuan JingLing-Hong LiuPublished in: Stem cell research & therapy (2020)
These results suggest hucMSC-based miRNA-126-3p gene therapy may be a novel option for the treatment of vein graft disease after CABG.